ALPINE IMMUNE SCIENCES, INC. Current Income Tax Expense (Benefit)
ALPINE IMMUNE SCIENCES, INC. reported Current Income Tax Expense (Benefit) of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2024-05-09
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for the quarter ending 2024-03-31 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for the quarter ending 2023-12-31 was -$51.00K, a 105.19% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for the quarter ending 2023-09-30 was $0.00.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for fiscal 2023 was -$51.00K, a 102.23% decline from fiscal 2022.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for fiscal 2022 was $2.28M, a 1668.99% increase from fiscal 2021.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for fiscal 2021 was $129.00K.
- ALPINE IMMUNE SCIENCES, INC. current income tax expense (benefit) for fiscal 2020 was -$6.00K.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | -$51.00K derived: sum of 2 quarters · filed 2024-05-09 | -$51.00K derived: sum of 3 quarters · filed 2024-05-09 | -$51.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$51.00K derived: sum of 2 quarters · filed 2024-03-20 | -$51.00K derived: sum of 3 quarters · filed 2024-03-20 | -$51.00K 10-K · filed 2024-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $982.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $982.00K derived: sum of 3 quarters · filed 2024-05-09 | $982.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $982.00K derived: sum of 2 quarters · filed 2024-05-09 | $982.00K derived: sum of 3 quarters · filed 2024-05-09 | $2.28M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $982.00K derived: sum of 2 quarters · filed 2024-03-20 | $2.28M derived: sum of 3 quarters · filed 2024-03-20 | $2.28M 10-K · filed 2024-03-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.30M derived: sum of 2 quarters · filed 2023-11-14 | $1.30M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $1.30M 10-Q · filed 2022-11-14 | $1.30M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $129.00K 10-K · filed 2024-03-20 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$6.00K 10-K · filed 2023-03-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-17 |